Related Experiment Videos
Antimutagenicity of benzo[a]phenothiazines in chemically induced mutagenesis
1Faculty of Medicine, Institute of Microbiology, Albert Szent-Györgyi Medical University, Szeged, Hungary.
Abstract:
The antimutagenicity of seven benzo[a]phenothiazines was screened against Salmonella typhimurium strain TA98 treated with 4-nitro-o-phenylenediamine which is a specific mutagen to the strain, and the results were compared to the antimutagenic activity of chlorpromazine (8), one of the 2-chlorophenothiazine derivatives-which have been shown to be the most effective mutagen inhibitors. Benzo[a]phenothiazines with methyl, oxo or hydroxyl substituent(s) at position 5, 6, 9 or 10 were used in the screening tests. 6-Hydroxy-5-oxo-5H-benzo[a]phenothiazine (6) reduced the induced mutation by 27%, being a more potent antimutagenic agent than chlorpromazine (8). The study of antimutagenicity is of great interest for the development of cancer chemopreventive agents which stop cancer progression in multistage carcinogenesis in which successive mutation sequences are required for a progression into full-fledged metastatic cancer.
Insights
Seven benzo[a]phenothiazines were screened for antimutagenicity. 6-Hydroxy-5-oxo-5H-benzo[a]phenothiazine demonstrated potent antimutagenic activity, exceeding that of chlorpromazine, suggesting potential in cancer chemoprevention.
Area of Science:
- Pharmacology
- Medicinal Chemistry
- Toxicology
Background:
- Antimutagenicity is crucial for developing cancer chemopreventive agents.
- Multistage carcinogenesis involves successive mutation sequences.
- Phenothiazine derivatives are known mutagen inhibitors.
Purpose of the Study:
- To screen the antimutagenicity of seven benzo[a]phenothiazines.
- To compare their efficacy against chlorpromazine, a known mutagen inhibitor.
- To identify novel compounds with potential cancer chemopreventive properties.
Main Methods:
- Screening of seven benzo[a]phenothiazines against Salmonella typhimurium strain TA98.
- Treatment with 4-nitro-o-phenylenediamine, a specific mutagen.
- Comparative analysis with the antimutagenic activity of chlorpromazine.
Main Results:
- Benzo[a]phenothiazines with methyl, oxo, or hydroxyl substituents at positions 5, 6, 9, or 10 were tested.
- 6-Hydroxy-5-oxo-5H-benzo[a]phenothiazine reduced induced mutation by 27%.
- This compound exhibited greater antimutagenic potency than chlorpromazine.
Conclusions:
- 6-Hydroxy-5-oxo-5H-benzo[a]phenothiazine is a potent antimutagenic agent.
- This finding holds significant interest for developing novel cancer chemopreventive agents.
- Further research into benzo[a]phenothiazines could lead to effective strategies against multistage carcinogenesis.